Mengting Shen

Statistics

Publications

Citations

160

H-Index

Active since

2019

Affiliations

Fudan University Shanghai Cancer Center(Current)

Shanghai Jiao Tong University

Shanghai First People's Hospital

Fudan University

Mengting Shen is an author at Fudan University Shanghai Cancer Center specializing in molecular oncology, liver cancer, and hepatocellular carcinoma pathogenesis.

Publications per year

2019–2022

Publications

LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR‐10a‐5p/NCOR2 axis in hepatocellular carcinoma cells

Yangjun Wu, Yuqiang Zhou, Lin Huan et al. · Cancer Science · 2019 · 75 citations · Full text

Medicine, Cancer Biology, Molecular Biology +17

RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma

Yejun Qiao, Qili Shi, Xu Yuan et al. · Cancer Letters · 2022 · 38 citations

Life Sciences, Molecular Biology, Oncology +15

Hepatic ARID3A facilitates liver cancer malignancy by cooperating with CEP131 to regulate an embryonic stem cell-like gene signature

Mengting Shen, Shengli Li, Yiming Zhao et al. · Cell Death and Disease · 2022 · 24 citations · Full text

Medicine, Genetics, Oncology +15

The Mutational and Transcriptional Landscapes of Hepatocarcinogenesis in a Rat Model

Zhiao Chen, Shengli Li, Mengting Shen et al. · iScience · 2020 · 23 citations · Full text

Medicine, Immunology, Oncology +17

1–4 of 4